BE1011045A3
(fr)
*
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
FR2772615B1
(fr)
*
|
1997-12-23 |
2002-06-14 |
Lipha |
Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
|
GB9901688D0
(en)
*
|
1999-01-26 |
1999-03-17 |
Unilever Plc |
Detergent compositions
|
AR030557A1
(es)
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
US6960357B2
(en)
*
|
2001-05-25 |
2005-11-01 |
Mistral Pharma Inc. |
Chemical delivery device
|
US7052706B2
(en)
*
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
CA2409552A1
(en)
*
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
AU2002358270A1
(en)
*
|
2001-12-20 |
2003-07-09 |
Pharmacia Corporation |
Zero-order sustained released dosage forms and method of making the same
|
EP1485078B1
(en)
*
|
2002-03-15 |
2012-09-26 |
Cypress Bioscience, Inc. |
Milnacipran for the treatment of irritable bowel syndrome
|
US20040132826A1
(en)
*
|
2002-10-25 |
2004-07-08 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
US20060003004A1
(en)
*
|
2002-10-25 |
2006-01-05 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
ATE402703T1
(de)
*
|
2002-12-06 |
2008-08-15 |
Ucb Farchim Sa |
Tablette enthaltend efletirizin und pseudoephedrin
|
CA2513893A1
(en)
*
|
2003-01-28 |
2004-08-12 |
Collegium Pharmaceutical, Inc. |
Multiparticulate compositions of milnacipran for oral administration
|
MXPA05009469A
(es)
*
|
2003-03-04 |
2005-12-12 |
Nostrum Pharmaceuticals Inc |
Formulacion de liberacion controlada que contiene un material hidrofobico como agente de liberacion prolongada.
|
PL196544B1
(pl)
*
|
2003-08-08 |
2008-01-31 |
Biovail Lab Int Srl |
Tabletka o zmodyfikowanym uwalnianiu
|
ES2390879T3
(es)
*
|
2003-12-31 |
2012-11-19 |
Actavis Group Ptc Ehf. |
Formulaciones de atomoxetina
|
KR20070043806A
(ko)
*
|
2004-07-29 |
2007-04-25 |
사노피-아벤티스 |
pH에 매우 의존적인 용해도를 가지는 활성 성분의 제어방출을 위한 약제학적 다층 정제
|
US20080248107A1
(en)
*
|
2005-08-24 |
2008-10-09 |
Rubicon Research Pvt. Ltd. |
Controlled Release Formulation
|
US8691272B2
(en)
*
|
2005-12-30 |
2014-04-08 |
Intelgenx Corp. |
Multilayer tablet
|
JP4953673B2
(ja)
*
|
2006-03-22 |
2012-06-13 |
リンテック株式会社 |
経口投与剤
|
US20080107725A1
(en)
*
|
2006-10-13 |
2008-05-08 |
Albano Antonio A |
Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
|
KR100885029B1
(ko)
*
|
2007-02-07 |
2009-02-23 |
지엘팜텍 주식회사 |
경구투여용 서방성 삼중정제
|
JP2011512349A
(ja)
*
|
2008-02-15 |
2011-04-21 |
サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド |
経口放出制御錠剤
|
US20100260842A1
(en)
*
|
2009-04-06 |
2010-10-14 |
Rashmi Nair |
Pseudoephedrine pharmaceutical formulations
|
US9173845B2
(en)
*
|
2009-08-05 |
2015-11-03 |
Lupin Limited |
Controlled release pharmaceutical compositions of milnacipran
|
US9572909B2
(en)
*
|
2009-09-14 |
2017-02-21 |
Virginia Commonwealth University |
Electrospun nerve guides for nerve regeneration designed to modulate nerve architecture
|
US10610528B2
(en)
|
2009-12-08 |
2020-04-07 |
Intelgenx Corp. |
Solid oral film dosage forms and methods for making same
|
US20110136815A1
(en)
|
2009-12-08 |
2011-06-09 |
Horst Zerbe |
Solid oral film dosage forms and methods for making same
|
WO2011078993A1
(en)
*
|
2009-12-21 |
2011-06-30 |
Aptapharma, Inc. |
Functionally-coated multilayer tablets
|
GB2479213B
(en)
|
2010-04-01 |
2013-07-10 |
Theravida Inc |
Pharmaceutical formulations for the treatment of overactive bladder
|
EP3405191A4
(en)
|
2016-01-20 |
2019-09-04 |
TheraVida, Inc. |
METHOD AND COMPOSITIONS FOR TREATING HYPERHIDROSIS
|